Cargando…

Combination of umbilical cord mesenchymal stem cells and standard immunosuppressive regimen for pediatric patients with severe aplastic anemia

BACKGROUND: Defects of bone marrow mesenchymal stem cells (BM-MSCs) in proliferation and differentiation are involved in the pathophysiology of aplastic anemia (AA). Infusion of umbilical cord mesenchymal stem cells (UC-MSCs) may improve the efficacy of immunosuppressive therapy (IST) in childhood s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lan, Yang, Liu, Fang, Chang, Lixian, Liu, Lipeng, Zhang, Yingchi, Yi, Meihui, Cai, Yuli, Feng, Jing, Han, Zhibo, Han, Zhongchao, Zhu, Xiaofan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7912947/ https://www.ncbi.nlm.nih.gov/pubmed/33639900 http://dx.doi.org/10.1186/s12887-021-02562-x

Ejemplares similares

Successful Treatment of a 19-Month-Old Boy with Hepatitis Associated Aplastic Anemia by Infusion of Umbilical Cord-Derived Mesenchymal Stromal Cells: A Case Report
por: Fang, Liu, et al.
Publicado: (2021)

Clinical observations on intensive immunosuppressive therapy combined with umbilical cord blood support for the treatment of severe aplastic anemia
por: Zhou, Fang, et al.
Publicado: (2011)

Effects and Predictive Factors of Immunosuppressive Therapy Combined with Umbilical Cord Blood Infusion in Patients with Severe Aplastic Anemia
por: Zhang, Xia, et al.
Publicado: (2018)

Umbilical cord-derived mesenchymal stem cells cultured in the MCL medium for aplastic anemia therapy
por: He, Chuan, et al.
Publicado: (2023)

Aplastic anemia: immunosuppressive therapy in 2010
por: Risitano, Antonio M., et al.
Publicado: (2011)

P761: UMBILICAL CORD BLOOD ORIGIN CELLS RECONSTRUCT THE HEMATOPOIESIS OF APLASTIC ANEMIA ANIMAL MODEL
por: Chen, Zesong, et al.
Publicado: (2023)

Efficacy and safety of combined immunosuppressive therapy plus umbilical cord blood infusion in severe aplastic anemia patients: A cohort study
por: Luo, Xiu, et al.
Publicado: (2018)

PB1932: GENERIC ELTHROMBOPAG WITH STANDARD IMMUNOSUPPRESSIVE THERAPY IN SEVERE APLASTIC ANEMIA
por: Ranjit Kumar, C., et al.
Publicado: (2022)

Immunosuppressive Treatment in Children with Acquired Aplastic Anemia
por: Yıldırmak, Yıldız, et al.
Publicado: (2012)

An investigation of long-term outcome of rabbit anti-thymocyte globulin and cyclosporine therapy for pediatric severe aplastic anemia
por: Chang, Lixian, et al.
Publicado: (2023)

Immunosuppressive therapy for pediatric aplastic anemia: a North American Pediatric Aplastic Anemia Consortium study
por: Rogers, Zora R., et al.
Publicado: (2019)

Clinical evaluation of haploidentical hematopoietic combined with human umbilical cord-derived mesenchymal stem cells in severe aplastic anemia
por: Xu, Lixin, et al.
Publicado: (2018)

Efficacy of eltrombopag with immunosuppressive therapy for children with acquired aplastic anemia
por: Zhao, Yufei, et al.
Publicado: (2023)

A multicentre trial of intensive immunosuppressive therapy combined with umbilical cord blood for the treatment of severe aplastic anaemia
por: Zhou, Fang, et al.
Publicado: (2022)

Predicting response of severe aplastic anemia to immunosuppression combined with eltrombopag
por: Zaimoku, Yoshitaka, et al.
Publicado: (2021)

Thymoma followed by aplastic anemia - two different responses to immunosuppressive therapy
por: de Castro, Murilo Antunes, et al.
Publicado: (2011)

Aplastic Anemia in China
por: Liu, Chunyan, et al.
Publicado: (2018)

Impaired immunosuppressive effect of bone marrow mesenchymal stem cell-derived exosomes on T cells in aplastic anemia
por: Wang, Shichong, et al.
Publicado: (2023)

Efficacy and safety of immunosuppressive therapy in the treatment of seronegative hepatitis associated aplastic anemia
por: Chen, Hai-Fei, et al.
Publicado: (2014)

Immunosuppressive Therapy in Patients with Aplastic Anemia: A Single-Center Retrospective Study
por: Jalaeikhoo, Hasan, et al.
Publicado: (2015)

Impaired immunosuppressive role of myeloid-derived suppressor cells in acquired aplastic anemia
por: Dong, Peiyuan, et al.
Publicado: (2022)

Efficacy of combined immunosuppression with or without eltrombopag in children with newly diagnosed aplastic anemia
por: Goronkova, Olga, et al.
Publicado: (2022)

Interferon-γ alters the microRNA profile of umbilical cord-derived mesenchymal stem cells
por: Chi, Ying, et al.
Publicado: (2016)

Umbilical cord blood transplantation supplemented with the infusion of mesenchymal stem cell for an adolescent patient with severe aplastic anemia: a case report and review of literature
por: Luan, Chengxin, et al.
Publicado: (2015)

Immunosuppressive therapy for aplastic anemia: a single-center experience from western India
por: Shah, Sandip, et al.
Publicado: (2018)

Predictive value of T cell receptor repertoire profiling for immunosuppressive therapy in severe aplastic anemia
por: Chen, Cunte, et al.
Publicado: (2023)

Successful Salvage Unrelated Umbilical Cord Blood Transplantation with Two Units After Engraftment Failure with Single Unit in Severe Aplastic Anemia
por: Lee, Ji Won, et al.
Publicado: (2009)

Cephalosporin-induced recurrent aplastic anemia
por: Han, Jimin, et al.
Publicado: (2010)

P792: CLINICAL STUDY OF HETROMBOPAG COMBINED WITH CYCLOSPORINE A IN THE TREATMENT OF CHILDREN WITH NON-SEVERE APLASTIC ANEMIA
por: Chang, Lixian, et al.
Publicado: (2023)

Eltrombopag for the treatment of aplastic anemia: current perspectives
por: Lum, Su Han, et al.
Publicado: (2016)

Allo-HSCT compared with immunosuppressive therapy for acquired aplastic anemia: a system review and meta-analysis
por: Zhu, Yangmin, et al.
Publicado: (2020)

Predicting Response of Severe Aplastic Anemia to Rabbit-Antithymocyte Immunoglobulin Based Immunosuppressive Therapy Combined With Eltrombopag
por: Li, Ruixin, et al.
Publicado: (2022)

Combination of Haploidentical Hematopoietic Stem Cell Transplantation with Umbilical Cord-Derived Mesenchymal Stem Cells in Patients with Severe Aplastic Anemia: A Retrospective Controlled Study
por: Sheng, Xian-Fu, et al.
Publicado: (2022)

Idiopathic severe aplastic anemia with a delayed response to immunosuppressive therapy: a case report
por: Alzahrani, Nujood, et al.
Publicado: (2018)

Association between human leukocyte antigen and immunosuppressive treatment outcomes in Chinese patients with aplastic anemia
por: Chen, Lingyun, et al.
Publicado: (2023)

A Single-Centre Experience of First-Line Romiplostim and Immunosuppressive Therapy in Patients With Aplastic Anemia
por: Dhingra, Gaurav, et al.
Publicado: (2023)

A cohort study of immune and hematopoietic functionality changes in severe aplastic anemia patients treated with immunosuppressive therapy
por: Guan, Jing, et al.
Publicado: (2019)

High‐efficient generation of VCAM‐1(+) mesenchymal stem cells with multidimensional superiorities in signatures and efficacy on aplastic anaemia mice
por: Wei, Yimeng, et al.
Publicado: (2020)

A multicenter phase II study on the efficacy and safety of hetrombopag in patients with severe aplastic anemia refractory to immunosuppressive therapy
por: Peng, Guangxin, et al.
Publicado: (2022)

Idiopathic Aplastic Anemia: An Update
por: Solomou, Elena E.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_rh4udaf96vomc6c46uc0fl2rnt